Ortho Dermatologics announces FDA filing acceptance for IDP-121 acne treatment
Ortho Dermatologics, a Valeant division, announced the FDA has accepted the NDA for IDP-121 (tretinoin 0.05%) lotion (ALTRENO™1) with a PDUFA action date of Aug. 27, 2018. If approved, ALTRENO will be the first tretinoin product in lotion form rather than a gel or cream. January 12, 2018